Skip to main content
TipRanks
Go Ultimate75% OFF

Chemfab Alkalis Ltd. (CHEMFAB) AI Stock Analysis

0 Followers
IN:CHEMFAB

Chemfab Alkalis Ltd.

(NSE:CHEMFAB)

Select Model
Rating:47Neutral
Price Target:INR 314.00â–¼(-3.43% Downside)
Action:reiterated
Date:11/18/26

The score is primarily constrained by recent losses, declining revenue, and negative free cash flow, despite a solid balance sheet and manageable leverage. Technical trends remain weak overall, and the negative P/E ratio with a minimal dividend yield provides no valuation support.

Positive Factors
Balance Sheet ResilienceA sizable equity base and historically low leverage provide a financial cushion that can support continued operations through weaker trading conditions. Although debt has risen recently, the underlying capital structure remains a relative strength and offers some capacity to manage volatility.
Negative Factors
Revenue and Profitability WeaknessRecent revenue contraction and a return to losses point to weakened operating performance rather than simple earnings volatility. Negative FY2026 operating profit can reduce internal funding capacity, weaken returns on equity, and make a sustained recovery dependent on improved business conditions.

Chemfab Alkalis Ltd. (CHEMFAB) vs. iShares MSCI India ETF (INDA)

-50%-40%-30%-20%-10%0%10%IN:CHEMFAB-34.85%INDA-2.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 4.62B
Dividend Yield
0.39%
Average Volume (3M)
277
Price to Earnings (P/E)
-1397.6
Beta (1Y)
1.14
Revenue Growth
-15.22%
EPS Growth
94.97%
Country
India
Employees
219
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Chemfab Alkalis Ltd. Business Overview & Revenue Model

Company Description

Established in 1985 and headquartered in Chennai, India, Chemfab Alkalis Limited is an international manufacturer and vendor of inorganic chemical products. The company's business activities are structured around two main segments: Chemicals and Rela...

How the Company Makes Money

null

Chemfab Alkalis Ltd. Financial Statement Overview

Summary

The balance sheet is relatively strong, with growing equity, moderate leverage, and expanding assets. However, sharp profitability deterioration, recent losses, declining revenue, and deeply negative free cash flow weigh heavily on the overall financial profile.

Income Statement

42Neutral

Balance Sheet

63Positive

Cash Flow

48Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.92B3.11B3.34B3.27B3.31B2.71B
Gross Profit309.00M410.05M1.16B573.09M1.57B972.61M
EBITDA331.89M359.06M444.34M632.53M1.13B624.45M
Net Income-3.41M-34.27M-69.40M263.23M645.83M287.47M
Balance Sheet
Total Assets5.82B5.77B5.22B5.00B4.12B3.52B
Cash, Cash Equivalents and Short-Term Investments9.54M143.98M211.84M76.98M692.16M328.37M
Total Debt1.44B1.26B843.41M201.11M23.57M86.47M
Total Liabilities2.05B2.01B1.42B1.13B507.42M541.82M
Stockholders Equity3.78B3.75B3.80B3.87B3.61B2.98B
Cash Flow
Free Cash Flow0-603.87M399.09M-605.69M349.82M347.13M
Operating Cash Flow0308.32M399.09M313.54M925.95M549.10M
Investing Cash Flow0-808.36M-859.86M-1.10B-475.12M-210.25M
Financing Cash Flow0380.62M587.23M160.65M-88.92M-245.73M

Chemfab Alkalis Ltd. Technical Analysis

Technical Analysis SentimentNeutral
Last Price325.15

Price Trends

50DMA330.92Negative
100DMA349.00Negative
200DMA368.29Negative

Market Momentum

MACD-0.15Negative
RSI53.14Neutral
STOCH58.78Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMFAB, the sentiment is Neutral. The current price of 325.15 is above the 20-day moving average (MA) of 309.24, below the 50-day MA of 330.92, and below the 200-day MA of 368.29, indicating a neutral trend. The MACD of -0.15 indicates Negative momentum. The RSI at 53.14 is Neutral, neither overbought nor oversold. The STOCH value of 58.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:CHEMFAB.

Chemfab Alkalis Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

IN:CHEMFAB against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
IN:CHEMBONDIN:CHEMBOND61NeutralINR 2.65B18.77―0.94%0.83%-34.03%
IN:ALKALIIN:ALKALI56NeutralINR 794.24M30.44―1.35%13.73%―
IN:AARTISURFIN:AARTISURF55NeutralINR 4.63B15.54―0.19%35.30%95.10%
IN:VISHNUIN:VISHNU55NeutralINR 37.29B22.55―0.06%14.06%9.32%
IN:SUKHJITSIN:SUKHJITS52NeutralINR 4.91B10.80―0.64%9.42%97.19%
IN:CHEMFABIN:CHEMFAB47NeutralINR 4.74B-1397.61―0.39%-15.22%94.97%

* Basic Materials Sector Average

Performance Comparison

-40%-20%0%20%40%IN:CHEMFABIN:AARTISURFIN:ALKALIIN:CHEMBONDIN:SUKHJITSIN:VISHNUDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:CHEMFAB and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:CHEMFABChemfab Alkalis Ltd.325.15-169.75-34.30%
IN:AARTISURFAarti Surfactants Ltd.539.60101.3023.11%
IN:ALKALIAlkali Metals Ltd.75.57-6.23-7.62%
IN:CHEMBONDChembond Chemicals Limited209.5045.8328.00%
IN:SUKHJITSSukhjit Starch & Chemicals Ltd.156.706.964.65%
IN:VISHNUVishnu Chemicals Limited510.909.141.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026